secwatch.observer — SEC 8-K summary
======================================

Issuer:     MoonLake Immunotherapeutics (MLTX)
CIK:        0001821586
Form:       8-K
Filed at:   2025-06-06T23:59:59+00:00
Accession:  0001213900-25-052140
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

MoonLake shareholders elect all director nominees and approve auditor and say-on-pay at AGM
--------------------------------------------------------------------------------

- All three Class III director nominees elected: Dr. Jorge Santos da Silva, Simon Sturge, Dr. Andrew Phillips with over 53M votes for each.
- Ratification of Baker Tilly US, LLP as independent auditor approved: 59,310,209 for, 2,856 against, 8,438 abstentions.
- Advisory vote on executive compensation passed with 53,464,199 for, 109,913 against, 8,983 abstentions, 5,738,408 broker non-votes.
- Total shares entitled to vote: 63,474,253 Class A and 729,320 Class C ordinary shares as of record date April 10, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1821586/000121390025052140/0001213900-25-052140-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1821586/000121390025052140/ea0245015-8k_moonlake.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-052140

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer